{"id":62845,"date":"2026-05-06T18:23:41","date_gmt":"2026-05-06T22:23:41","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/new-pancreatic-cancer-drug-shows-promise-despite-high-side-effect-rate\/"},"modified":"2026-05-06T18:23:41","modified_gmt":"2026-05-06T22:23:41","slug":"new-pancreatic-cancer-drug-shows-promise-despite-high-side-effect-rate","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/new-pancreatic-cancer-drug-shows-promise-despite-high-side-effect-rate\/","title":{"rendered":"New Pancreatic Cancer Drug Shows Promise Despite High Side Effect Rate"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n

A groundbreaking experimental treatment for advanced pancreatic cancer has shown remarkable results in extending patient survival, though it comes with a significant rate of side effects that doctors say are largely treatable, according to new research published Wednesday.<\/p>

The medication, called daraxonrasib and developed by Revolution Medicines, represents what medical experts believe could establish a new treatment standard for patients battling metastatic pancreatic cancer who have already undergone previous therapies.<\/p>

Pancreatic cancer remains one of the most lethal cancer diagnoses worldwide, with approximately only 13% of patients surviving five years after diagnosis, making it among the deadliest cancer types.<\/p>

The latest research findings provide support for an ongoing advanced clinical trial that compares daraxonrasib against conventional second-round chemotherapy treatments for patients whose pancreatic cancer has metastasized throughout their bodies.<\/p>

During the initial human trial involving 168 patients with previously treated pancreatic ductal adenocarcinoma who took daraxonrasib, 96% experienced treatment-related adverse reactions of varying severity, while 30% faced serious or life-threatening complications.<\/p>

Patients most frequently reported experiencing skin rashes, mouth inflammation, nausea, and diarrhea as side effects from the treatment.<\/p>

“Almost all patients do experience some adverse effects, with the most common being a rash that occurs in the majority of patients,” said senior researcher Dr. David Hong of the University of Texas MD Anderson Cancer Center in Houston. “But those effects are manageable in most patients, and the benefits significantly outweigh those adverse effects.”<\/p>

Current results from the larger ongoing trial with 500 participants show patients taking daraxonrasib lived a median of 13.2 months compared to 6.7 months for those receiving standard chemotherapy, Revolution announced in April.<\/p>

Traditional treatment approaches for previously treated metastatic pancreatic cancer typically result in serious or life-threatening complications and provide median survival periods of just 5 to 7 months, researchers noted in their report published in The New England Journal of Medicine.<\/p>

Both clinical trials focused on patients carrying specific mutations in KRAS tumor genes, which enable cancer cells to reproduce and spread. While medications targeting these genes already exist for lung and colorectal cancer treatment, they work against a different RAS mutation that rarely appears in pancreatic cancer cases.<\/p>

Daraxonrasib, administered as a daily oral medication, specifically targets the RAS mutations present in 90% of pancreatic cancer diagnoses.<\/p>

“Although much work remains to be done, it genuinely feels like a new day is dawning for pancreatic cancer treatment, with daraxonrasib potentially serving as the first of a set of new medicines that broadly target mutant RAS and allow us to help patients with pancreatic cancers in new ways,” study leader Dr. Brian Wolpin of Dana-Farber Cancer Institute in Boston said in a statement.<\/p>

Earlier this month, the U.S. Food and Drug Administration granted early access authorization for daraxonrasib, enabling patients to receive the experimental therapy outside of clinical trials before official approval.<\/p>","protected":false},"excerpt":{"rendered":"

An experimental medication from Revolution Medicines nearly doubled survival times for advanced pancreatic cancer patients in clinical trials, though most participants experienced side effects. The drug, daraxonrasib, targets genetic mutations found in 90% of pancreatic cancers and could become the new standard treatment for patients whose cancer has already spread.<\/p>\n","protected":false},"author":4,"featured_media":62844,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[837],"tags":[],"class_list":["post-62845","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778106220782.png?fit=1920%2C1080&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-glD","jetpack-related-posts":[{"id":74478,"url":"https:\/\/tvdelmarva.com\/wp\/new-pancreatic-cancer-pill-shows-promise-in-clinical-trial\/","url_meta":{"origin":62845,"position":0},"title":"New Pancreatic Cancer Pill Shows Promise in Clinical Trial","author":"Admin","date":"May 31, 2026","format":false,"excerpt":"Researchers report that an experimental medication called daraxonrasib helped patients with advanced pancreatic cancer live nearly twice as long compared to traditional chemotherapy. The daily pill targets a mutated protein that drives tumor growth in over 90% of pancreatic cancer cases, offering new hope for one of the most deadly\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231021552.jpg?fit=1000%2C666&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231021552.jpg?fit=1000%2C666&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231021552.jpg?fit=1000%2C666&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231021552.jpg?fit=1000%2C666&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":74476,"url":"https:\/\/tvdelmarva.com\/wp\/experimental-cancer-pill-shows-breakthrough-results-for-pancreatic-cancer-patients\/","url_meta":{"origin":62845,"position":1},"title":"Experimental Cancer Pill Shows Breakthrough Results for Pancreatic Cancer Patients","author":"Admin","date":"May 31, 2026","format":false,"excerpt":"A new experimental medication for pancreatic cancer has shown remarkable results in clinical trials, doubling patient survival times compared to traditional chemotherapy. The once-daily pill reduced death risk by 60% and allowed some patients to return to activities they had given up due to their illness.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780230213574.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780230213574.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780230213574.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780230213574.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780230213574.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":66447,"url":"https:\/\/tvdelmarva.com\/wp\/cancer-centers-rush-to-provide-access-to-promising-pancreatic-cancer-treatment\/","url_meta":{"origin":62845,"position":2},"title":"Cancer Centers Rush to Provide Access to Promising Pancreatic Cancer Treatment","author":"Admin","date":"May 14, 2026","format":false,"excerpt":"Medical facilities across the country are working to enroll patients in an early access program for an experimental pancreatic cancer medication that showed remarkable results in clinical trials. The drug doubled survival times compared to chemotherapy and has generated overwhelming patient demand since the FDA approved expanded access on May\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778754316671.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778754316671.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778754316671.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778754316671.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778754316671.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":75990,"url":"https:\/\/tvdelmarva.com\/wp\/cancer-survival-rates-hit-record-high-as-targeted-treatments-transform-care\/","url_meta":{"origin":62845,"position":3},"title":"Cancer Survival Rates Hit Record High as Targeted Treatments Transform Care","author":"Admin","date":"June 3, 2026","format":false,"excerpt":"Seven out of ten cancer patients now survive at least five years, marking a record high as targeted therapies revolutionize treatment. The American Cancer Society reports 18 million Americans who have had cancer are alive today. Two women share their stories of living with cancer for years thanks to personalized\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1780483210863.jpg?fit=450%2C293&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":50890,"url":"https:\/\/tvdelmarva.com\/wp\/british-drugmaker-reports-promising-results-for-new-cancer-treatment\/","url_meta":{"origin":62845,"position":4},"title":"British Drugmaker Reports Promising Results for New Cancer Treatment","author":"Admin","date":"April 12, 2026","format":false,"excerpt":"GSK's experimental cancer drug Mo-rez showed significant tumor reduction in patients with advanced ovarian and endometrial cancers during early trials. The pharmaceutical company's oncology chief believes the treatment could become a blockbuster medication. Results will be presented at a medical conference this weekend.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1776007270513.jpg?fit=450%2C305&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":74480,"url":"https:\/\/tvdelmarva.com\/wp\/chinese-cancer-drug-shows-promise-extends-life-15-over-standard-treatment\/","url_meta":{"origin":62845,"position":5},"title":"Chinese Cancer Drug Shows Promise, Extends Life 15% Over Standard Treatment","author":"Admin","date":"May 31, 2026","format":false,"excerpt":"A new experimental cancer medication from China demonstrated significant benefits for lung cancer patients in a recent clinical trial. The drug, called ivonescimab, helped patients with advanced squamous non-small cell lung cancer live an average of four months longer than those receiving standard immunotherapy treatment.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231022696.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231022696.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231022696.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231022696.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1780231022696.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/62845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=62845"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/62845\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/62844"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=62845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=62845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=62845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}